A phase II study of docetaxel (D) followed by flavopiridol (F) in advanced, gemcitabine-refractory pancreatic cancer (PC) Meeting Abstract
| Authors: | Carvajal, R. D.; Shah, M. A.; Tse, A.; Lefkowitz, R.; Kelsen, D. P.; Schwartz, G. K.; O'Reilly, E. M. |
| Abstract Title: | A phase II study of docetaxel (D) followed by flavopiridol (F) in advanced, gemcitabine-refractory pancreatic cancer (PC) |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 659s |
| Language: | English |
| ACCESSION: | WOS:000208457401136 |
| DOI: | 10.1200/jco.2008.26.15_suppl.15558 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 15558 -- Full text available online only -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
